[go: up one dir, main page]

DE60235088D1 - Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel - Google Patents

Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel

Info

Publication number
DE60235088D1
DE60235088D1 DE60235088T DE60235088T DE60235088D1 DE 60235088 D1 DE60235088 D1 DE 60235088D1 DE 60235088 T DE60235088 T DE 60235088T DE 60235088 T DE60235088 T DE 60235088T DE 60235088 D1 DE60235088 D1 DE 60235088D1
Authority
DE
Germany
Prior art keywords
anticancer agent
fragments
genes
gene
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235088T
Other languages
English (en)
Inventor
Teiji Takechi
Katsuhisa Koizumi
Atsushi Azuma
Masakazu Fukushima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60235088D1 publication Critical patent/DE60235088D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60235088T 2001-07-05 2002-07-03 Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel Expired - Lifetime DE60235088D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001204448 2001-07-05
JP2001239181 2001-08-07
PCT/JP2002/006754 WO2003004640A1 (fr) 2001-07-05 2002-07-03 Reseaux d'adn permettant de mesurer la sensibilite a un agent anticancereux

Publications (1)

Publication Number Publication Date
DE60235088D1 true DE60235088D1 (de) 2010-03-04

Family

ID=26618186

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235088T Expired - Lifetime DE60235088D1 (de) 2001-07-05 2002-07-03 Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel

Country Status (6)

Country Link
US (1) US20040265813A1 (de)
EP (1) EP1411120B1 (de)
JP (1) JPWO2003004640A1 (de)
AT (1) ATE455187T1 (de)
DE (1) DE60235088D1 (de)
WO (1) WO2003004640A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687437B2 (en) 2001-07-13 2010-03-30 Nanosphere, Inc. Method for immobilizing molecules onto surfaces
US7297553B2 (en) 2002-05-28 2007-11-20 Nanosphere, Inc. Method for attachment of silylated molecules to glass surfaces
EP2385138A1 (de) * 2002-07-31 2011-11-09 University of Southern California Polymorphismen zur Vorhersage des Krankheits- und Behandlungsausgangs
PL1604991T3 (pl) * 2003-03-14 2009-02-27 Taiho Pharmaceutical Co Ltd Środek wzmacniający działanie przeciwnowotworowe i środek przeciwnowotworowy
AU2004262369A1 (en) * 2003-07-29 2005-02-10 Bristol-Myers Squibb Company Biomarkers of cyclin-dependent kinase modulation
JP2006042802A (ja) * 2004-06-28 2006-02-16 Sumitomo Chemical Co Ltd コモンマーモセット由来のヒポキサンチングアニンホスホリボシルトランスフェラーゼ遺伝子及びその利用
AU2005267148A1 (en) * 2004-07-01 2006-02-02 University Of Southern California Genetic markers for predicting disease and treatment outcome
KR101135789B1 (ko) * 2005-04-01 2012-04-16 다이호야쿠힌고교 가부시키가이샤 피리딘 유도체를 유효성분으로 하는 방사선 치료 증강제
EP1864683B1 (de) * 2005-04-01 2010-09-01 Taiho Pharmaceutical Co., Ltd. Strahlentherapieverstärker
WO2006132982A2 (en) * 2005-06-03 2006-12-14 Aviaradx, Inc. Normalization genes
US20100113299A1 (en) * 2008-10-14 2010-05-06 Von Hoff Daniel D Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
WO2007137187A2 (en) * 2006-05-18 2007-11-29 Molecular Profiling Institute, Inc. System and method for determining individualized medical intervention for a disease state
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
JP5413818B2 (ja) * 2007-03-29 2014-02-12 国立大学法人佐賀大学 蛍光多重染色による蛋白定量法
PT3301446T (pt) * 2009-02-11 2020-07-14 Caris Mpi Inc Perfilagem molecular de tumores
NZ593272A (en) * 2011-06-07 2013-02-22 Scott Pearson Breathing pipe with compartment having moutpiece and fan drivingly connected to a fan in another separated compartment to force air with active substance to outlet, typically near users nose to avoid nuisance to others
JPWO2016121715A1 (ja) * 2015-01-26 2017-11-02 国立大学法人名古屋大学 肺がん患者の予後を評価するための情報を提供する方法、肺がん患者の予後予測方法、内部標準、抗体、肺がん患者の予後予測装置、予後予測装置のプログラム及び記録媒体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US6025194A (en) * 1997-11-19 2000-02-15 Geron Corporation Nucleic acid sequence of senescence asssociated gene
US9534254B1 (en) * 1999-02-02 2017-01-03 Abbott Molecular Inc. Patient stratification for cancer therapy based on genomic DNA microarray analysis
AU1466001A (en) * 1999-11-05 2001-05-14 Phase-1 Molecular Toxicology Methods of determining individual hypersensitivity to an agent

Also Published As

Publication number Publication date
ATE455187T1 (de) 2010-01-15
EP1411120B1 (de) 2010-01-13
JPWO2003004640A1 (ja) 2004-10-28
EP1411120A4 (de) 2006-09-06
US20040265813A1 (en) 2004-12-30
WO2003004640A1 (fr) 2003-01-16
EP1411120A1 (de) 2004-04-21

Similar Documents

Publication Publication Date Title
DE60235088D1 (de) Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel
Chen et al. Alternative polyadenylation: methods, findings, and impacts
Burmistrova et al. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11)
JP2019526257A5 (de)
CA3077750C (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
US20150299796A1 (en) Prediction of treatment response to jak/stat inhibitor
JP5769952B2 (ja) Eml4−alk融合遺伝子の高感度検出方法
CN111944809B (zh) 帕金森病的诊断标志物及其应用
CN108949992B (zh) 一种与食管鳞癌及其分级相关的生物标志物
CN104937112A (zh) 对WT1 mRNA的表达量进行定量的方法
Wong et al. Identification of novel microRNAs in the sheep heart and their regulation in heart failure
Guenel et al. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer
KR102202726B1 (ko) 편평상피세포암의 진단 또는 예후 예측용 마커 및 이의 용도
AU614489B2 (en) Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells
CN110820051A (zh) 一种高灵敏度融合基因检测方法及其应用
WO2001092538A1 (fr) Technique de detection et de quantification de l'espece moleculaire humaine p450, sonde et necessaire a cet effet
CN109735622A (zh) 与结直肠癌相关的lncRNA及其应用
EP3321377B1 (de) Verfahren zur bestimmung der empfindlichkeit auf simultanen inhibitor gegen parp und tankyrase
CN107312851A (zh) 心肌梗死生物标志物miR‑1283
CN108165546A (zh) 一种miRNA生物标志物、组合物及其用途
KR20210066634A (ko) Parp1 저해제 내성 암의 진단를 위한 조성물, 키트 및 방법
CN112921098B (zh) 一种用于三阴性乳腺癌检测的标志物及其检测试剂和应用
CN102094070A (zh) HER2过量表达的mRNA原位杂交检测试剂盒
RU2451937C2 (ru) Способ диагностики рака молочной железы по уровню рнк интерлейкинов il-8 и/или il-18 в плазме крови
CN109652529A (zh) 骨质疏松特异性miRNA、组合物及其诊疗用途

Legal Events

Date Code Title Description
8364 No opposition during term of opposition